These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33550112)

  • 1. Citrulline supplementation attenuates the development of non-alcoholic steatohepatitis in female mice through mechanisms involving intestinal arginase.
    Rajcic D; Baumann A; Hernández-Arriaga A; Brandt A; Nier A; Jin CJ; Sánchez V; Jung F; Camarinha-Silva A; Bergheim I
    Redox Biol; 2021 May; 41():101879. PubMed ID: 33550112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral citrulline supplementation protects female mice from the development of non-alcoholic fatty liver disease (NAFLD).
    Sellmann C; Jin CJ; Engstler AJ; De Bandt JP; Bergheim I
    Eur J Nutr; 2017 Dec; 56(8):2519-2527. PubMed ID: 27496089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of nitric oxide homeostasis as trigger of intestinal barrier dysfunction in non-alcoholic fatty liver disease.
    Baumann A; Rajcic D; Brandt A; Sánchez V; Jung F; Staltner R; Nier A; Trauner M; Staufer K; Bergheim I
    J Cell Mol Med; 2022 Feb; 26(4):1206-1218. PubMed ID: 35029027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: Role of intestinal barrier function.
    Brandt A; Nier A; Jin CJ; Baumann A; Jung F; Ribas V; García-Ruiz C; Fernández-Checa JC; Bergheim I
    Redox Biol; 2019 Feb; 21():101092. PubMed ID: 30605883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventive effects of citrulline on Western diet-induced non-alcoholic fatty liver disease in rats.
    Jegatheesan P; Beutheu S; Freese K; Waligora-Dupriet AJ; Nubret E; Butel MJ; Bergheim I; De Bandt JP
    Br J Nutr; 2016 Jul; 116(2):191-203. PubMed ID: 27197843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis.
    Baumann A; Jin CJ; Brandt A; Sellmann C; Nier A; Burkard M; Venturelli S; Bergheim I
    Nutrients; 2020 Mar; 12(4):. PubMed ID: 32235497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment.
    Brandt A; Jin CJ; Nolte K; Sellmann C; Engstler AJ; Bergheim I
    Nutrients; 2017 Sep; 9(9):. PubMed ID: 28906444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine.
    Brandt A; Hernández-Arriaga A; Kehm R; Sánchez V; Jin CJ; Nier A; Baumann A; Camarinha-Silva A; Bergheim I
    Sci Rep; 2019 Apr; 9(1):6668. PubMed ID: 31040374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citrulline decreases hepatic endotoxin-induced injury in fructose-induced non-alcoholic liver disease: an ex vivo study in the isolated perfused rat liver.
    Ouelaa W; Jegatheesan P; M'bouyou-Boungou J; Vicente C; Nakib S; Nubret E; De Bandt JP
    Br J Nutr; 2017 Jun; 117(11):1487-1494. PubMed ID: 28637520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fortifying diet with rapeseed oil instead of butterfat attenuates the progression of diet-induced non-alcoholic fatty liver disease (NAFLD) and impairment of glucose tolerance.
    Brandt A; Rajcic D; Jin CJ; Sánchez V; Engstler AJ; Jung F; Nier A; Baumann A; Bergheim I
    Metabolism; 2020 Aug; 109():154283. PubMed ID: 32497536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fortifying Butterfat with Soybean Oil Attenuates the Onset of Diet-Induced Non-Alcoholic Steatohepatitis and Glucose Intolerance.
    Sánchez V; Brandt A; Jin CJ; Rajcic D; Engstler AJ; Jung F; Nier A; Baumann A; Bergheim I
    Nutrients; 2021 Mar; 13(3):. PubMed ID: 33809593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moderate consumption of fermented alcoholic beverages diminishes diet-induced non-alcoholic fatty liver disease through mechanisms involving hepatic adiponectin signaling in mice.
    Jung F; Lippmann T; Brandt A; Jin CJ; Engstler AJ; Baumann A
    Eur J Nutr; 2020 Mar; 59(2):787-799. PubMed ID: 30879098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GW9662, a peroxisome proliferator-activated receptor gamma antagonist, attenuates the development of non-alcoholic fatty liver disease.
    Baumann A; Burger K; Brandt A; Staltner R; Jung F; Rajcic D; Lorenzo Pisarello MJ; Bergheim I
    Metabolism; 2022 Aug; 133():155233. PubMed ID: 35654114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Supplementation of Glutamine Attenuates the Progression of Nonalcoholic Steatohepatitis in C57BL/6J Mice.
    Sellmann C; Baumann A; Brandt A; Jin CJ; Nier A; Bergheim I
    J Nutr; 2017 Nov; 147(11):2041-2049. PubMed ID: 28931589
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral arginine supplementation protects female mice from the onset of non-alcoholic steatohepatitis.
    Sellmann C; Degen C; Jin CJ; Nier A; Engstler AJ; Hasan Alkhatib D; De Bandt JP; Bergheim I
    Amino Acids; 2017 Jul; 49(7):1215-1225. PubMed ID: 28434046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time.
    Sellmann C; Priebs J; Landmann M; Degen C; Engstler AJ; Jin CJ; Gärttner S; Spruss A; Huber O; Bergheim I
    J Nutr Biochem; 2015 Nov; 26(11):1183-92. PubMed ID: 26168700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotics attenuate diet-induced nonalcoholic fatty liver disease without altering intestinal barrier dysfunction.
    Brandt A; Csarmann K; Hernández-Arriaga A; Baumann A; Staltner R; Halilbasic E; Trauner M; Camarinha-Silva A; Bergheim I
    J Nutr Biochem; 2024 Jan; 123():109495. PubMed ID: 37871765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of specific amino acids on hepatic lipid metabolism in fructose-induced non-alcoholic fatty liver disease.
    Jegatheesan P; Beutheu S; Ventura G; Sarfati G; Nubret E; Kapel N; Waligora-Dupriet AJ; Bergheim I; Cynober L; De-Bandt JP
    Clin Nutr; 2016 Feb; 35(1):175-182. PubMed ID: 25736031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental non-alcoholic steatohepatitis in Göttingen Minipigs: consequences of high fat-fructose-cholesterol diet and diabetes.
    Schumacher-Petersen C; Christoffersen BØ; Kirk RK; Ludvigsen TP; Zois NE; Pedersen HD; Vyberg M; Olsen LH
    J Transl Med; 2019 Apr; 17(1):110. PubMed ID: 30943987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Supplementation of Phosphatidylcholine Attenuates the Onset of a Diet-Induced Metabolic Dysfunction-Associated Steatohepatitis in Female C57BL/6J Mice.
    Sánchez V; Baumann A; Brandt A; Wodak MF; Staltner R; Bergheim I
    Cell Mol Gastroenterol Hepatol; 2024; 17(5):785-800. PubMed ID: 38262589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.